MacroGenics
MGNX
#9393
Rank
HK$0.67 B
Marketcap
HK$10.66
Share price
-0.72%
Change (1 day)
-59.57%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): -HK$0.43

According to MacroGenics's latest financial reports the company's current EPS (TTM) is -HK$0.39. In 2024 the company made an earnings per share (EPS) of -HK$8.33 a decrease over its 2023 EPS that were of -HK$1.17.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$0.43-94.8%
2024-HK$8.33613.33%
2023-HK$1.17-92.31%
2022-HK$15.18-42.14%
2021-HK$26.2336.44%
2020-HK$19.23-21.84%
2019-HK$24.60-24.58%
2018-HK$32.62675.93%
2017-HK$4.20-68.05%
2016-HK$13.16168.25%
2015-HK$4.90-55%
2014-HK$10.903400%
2013-HK$0.31-108.68%
2012HK$3.5924.49%
2011HK$2.88

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Xencor
XNCR
-HK$13.78 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$13.39-3,540.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$59.11-15,287.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$50.76-13,140.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$101.43-26,160.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$159.73-41,136.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$23.12-6,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA